MedPath

The Effect of Intensive Dietary Education on Nutritional Status After Gastrectomy(SING)

Not Applicable
Recruiting
Conditions
Gastric Cancer
Gastrectomy
Interventions
Other: Dietary education(nutritional counselling)
Registration Number
NCT04798820
Lead Sponsor
Samsung Medical Center
Brief Summary

Radical gastrectomy has been known as the most effective treatment of curable gastric cancer.However, there is a high risk of malnutrition and weight loss after a gastrectomy which may be attributed to inadequate oral consumption, malabsorption and loss of the reservoir function of the stomach.Weight loss has been regarded as an independent risk factor for postoperative mortality and morbidity and It is also closely associated with a quality of life after surgery. No specific surgical technique has been proved to be effective in reducing postoperative weight loss and it seems like that dietary education and consultation is the best way to minimize weight loss in gastrectomy patients in clinical setting. In this regard, the investigators performed a retrospective pilot study to identify the effect of routinely performed (simplified) dietary education on nutritional status after gastrectomy, but it revealed that the effect of simplified dietary education on weight loss was not clear and the result implies that more intensive dietary education may be necessary after gastrectomy. The aim of this randomized controlled trial (RCT) is to elucidate the effect of intensive dietary education on nutritional status after gastrectomy in comparison with simplified dietary education.

Detailed Description

Subject 1: subtotal gastrectomy group

subject 2: total gastrectomy group

Objectives:

Primary objective: to evaluate Weight loss difference of simplified dietary education(SE) versus intensive dietary education(IE) for patients after undergoing a gastrectomy

Primary endpoint: Superiority of weight loss difference (%) of IE group between post op 1mo and 12mo

Secondary objectives:

weight loss(%) of each subgroup, nutritional parameters (PG-SGA), Calrorie intake \& dietary habits, albumin, hemoglobin, iron panel (TIBC, ferritin), Absolute lymphocyte count(ALC), vit B12, homocysteine, quality of life(QOL) change

1. Nutritional parameters (PG-SGA)

2. the amount of calorie intake (Kcal, protein) \& dietary habits

3. Albumin (g/dL)

4. Hemoglobin (g/dL)

5. Iron panel \[TIBC (μg/dL), Ferritin (ng/mL)\]

6. Absolute lymphocyte count (ALC) (10\^3/μL)

7. Vitamin B12 (pg/mL)

8. Homocysteine (μmol/L)

9. Quality of life of the patients in terms of European quality of life questionnaire (EQ-5D)

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
358
Inclusion Criteria
  • histologically proven primary gastric adenocarcinoma,

  • T1N0, T1N1, T2N0, which are assessed by computed tomography (CT) scan (AJCC 8th classification) and intraoperative surgical staging

  • location of primary tumor; antrum, or angle, , lower body or mid body of the stomach

  • No evidence of other distant metastasis,

  • age ≥ 20 year old, ≤ 75 year old

  • no prior or posterior treatment of chemotherapy or radiation therapy against any other malignancies

  • adequate organ functions defined as indicated below:

    1. WBC count: 3000/mm3 ~12,000/mm3,
    2. > serum Hemoglobin 8.0 g/dL
    3. > serum Platelet 100 000/mm3,
    4. < serum AST 100 IU/L,
    5. <serum ALT 100 IU/L,
    6. < Total Bilirubin 2.0 mg/dL,
  • written signed informed consent

Exclusion Criteria
  • active double cancer (synchronous double cancer and metachronous double cancer within five disease-free years), excluding carcinoma in situ (lesions equal to intraepithelial or intramucosal cancer),
  • gastric remnant cancer
  • ≥T3, T4 in surgical staging before resection
  • N2 or more (number of metastatic lymph nodes ≥3) in CT scan
  • histologically rare variants in World Health Organization (WHO) Classification such as Adenosquamous, Hepatoid, Squamous cell, Undifferentiated, neuroendocrine carcinoma and others
  • pregnant or breast-feeding women,
  • mental disorder(diagnosed with mental disorder on medical record),
  • unstable angina or myocardial infarction within 6 months of the trial,
  • unstable hypertension,
  • diabetes mellitus on insulin,
  • severe respiratory disease requiring continuous oxygen therapy,
  • previous upper abdominal surgery except laparoscopic cholecystectomy,
  • surgical complication

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
SE-TGDietary education(nutritional counselling)simplified dietary education arm in total gastrectomy group.
IE-TGDietary education(nutritional counselling)intensive dietary education arm in total gastrectomy group
SE-STGDietary education(nutritional counselling)simplified dietary education arm in subtotal gastrectomy group.
IE-STGDietary education(nutritional counselling)intensive dietary education arm in subtotal gastrectomy group
Primary Outcome Measures
NameTimeMethod
Change from preoperative weight change at postoperaive 12 months in SE and IE groups.preoperative, postoperative 12 months

comparison of weight change between the two groups after surgery

Change from preoperative weight change at immediate postoperative period in SE and IE groups.preoperative, immediate postoperative

comparison of weight change between the two groups after surgery

Change from preoperative weight change at postoperaive 6 months in SE and IE groups.preoperative, postoperative 6 months

comparison of weight change between the two groups after surgery

Change from preoperative weight change at postoperaive 1 month in SE and IE groups.preoperative, postoperative 1 month

comparison of weight change between the two groups after surgery

Change from preoperative weight change at postoperaive 3 months in SE and IE groups.preoperative, postoperative 3 months

comparison of weight change between the two groups after surgery

Change from preoperative weight change at postoperaive 18 months in SE and IE groups.preoperative, postoperative 18 months

comparison of weight change between the two groups after surgery

Secondary Outcome Measures
NameTimeMethod
24hrs dietary recallpreoperative, immediate postoperative, postoperative 1 month, 3 months, 6months, 12 months, 18 months

calculating kcal \& protein intake by 24hrs dietary recall (questionnaire)

Nutritional parameterspreoperative, immediate postoperative, postoperative 1 month, 3 months, 6months, 12 months, 18 months

measured by Patient-Generated Subjective Global Assessment (PG-SGA; rating A,B,C)

Albuminpreoperative, immediate postoperative, postoperative 1 month, 3 months, 6months, 12 months, 18 months

g/dL

Ferritinpreoperative, immediate postoperative, postoperative 1 month, 3 months, 6months, 12 months, 18 months

ng/mL

Quality of life of the patientspreoperative, immediate postoperative, postoperative 1 month, 3 months, 6months, 12 months, 18 months

European quality of life questionnaire (EQ-5D); the descriptive system which comprises 5 dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 3 levels: no problems, some problems, extreme problems (labelled 1-3).

dietary habitspreoperative, immediate postoperative, postoperative 1 months, 3 months, 6months, 12 months, 18 months

number of meals, eating speed (questionnaire)

Hemoglobinpreoperative, immediate postoperative, postoperative 1 month, 3 months, 6months, 12 months, 18 months

g/dL

Vitamin B12preoperative, immediate postoperative, postoperative 1 month, 3 months, 6months, 12 months, 18 months

pg/mL

Total iron binding capacity (TIBC)preoperative, immediate postoperative, postoperative 1 month, 3 months, 6months, 12 months, 18 months

μg/dL

Absolute lymphocyte count (ALC)preoperative, immediate postoperative, postoperative 1 month, 3 months, 6months, 12 months, 18 months

10\^3/μL

Homocysteinepreoperative, immediate postoperative, postoperative 1 month, 3 months, 6months, 12 months, 18 months

μmol/L

Trial Locations

Locations (1)

Samsung medical center

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath